Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SKLB-197

Copy Product Info
😃Good
Catalog No. T62290Cas No. 2713577-16-1
Alias SKLB197, SKLB 197

SKLB-197 is a potent and highly selective inhibitor of ataxia telangiectasia and Rad3-related kinase (ATR) with an IC50 value of 0.013 μM and minimal activity against more than 402 other kinases. SKLB-197 shows strong antitumor efficacy in ATM-deficient tumors both in vitro and in vivo, while also exhibiting favorable pharmacokinetic properties for oncology research.

SKLB-197

SKLB-197

Copy Product Info
😃Good
Purity: 99.53%
Catalog No. T62290Alias SKLB197, SKLB 197Cas No. 2713577-16-1
SKLB-197 is a potent and highly selective inhibitor of ataxia telangiectasia and Rad3-related kinase (ATR) with an IC50 value of 0.013 μM and minimal activity against more than 402 other kinases. SKLB-197 shows strong antitumor efficacy in ATM-deficient tumors both in vitro and in vivo, while also exhibiting favorable pharmacokinetic properties for oncology research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$74-In Stock
5 mg$179-In Stock
10 mg$289-In Stock
25 mg$579-In Stock
50 mg$928-In Stock
100 mg$1,490-In Stock
1 mL x 10 mM (in DMSO)$198-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.53%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
SKLB-197 is a potent and highly selective inhibitor of ataxia telangiectasia and Rad3-related kinase (ATR) with an IC50 value of 0.013 μM and minimal activity against more than 402 other kinases. SKLB-197 shows strong antitumor efficacy in ATM-deficient tumors both in vitro and in vivo, while also exhibiting favorable pharmacokinetic properties for oncology research.
Targets&IC50
ATR:> 10 μM
In vitro
In enzymatic assays, SKLB-197 inhibited ATR kinase (IC50 = 13 nM) with selectivity over ATM and DNA-PK. In cellular models, it inhibited UV- or Gemcitabine-induced CHK1 phosphorylation and demonstrated antiproliferative activity against cancer cells with high replication stress, leading to cell cycle arrest and apoptosis [1].
SynonymsSKLB197, SKLB 197
Chemical Properties
Molecular Weight424.5
FormulaC25H24N6O
Cas No.2713577-16-1
SmilesC[C@H]1N(C=2C3=C(N=C(N2)C4=C5C(NC=C5)=CC=C4)C=CC(=C3)C=6N(C)N=CC6)CCOC1
Storage & Solubility Information
Storagestore at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (188.46 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3557 mL11.7786 mL23.5571 mL117.7856 mL
5 mM0.4711 mL2.3557 mL4.7114 mL23.5571 mL
10 mM0.2356 mL1.1779 mL2.3557 mL11.7786 mL
20 mM0.1178 mL0.5889 mL1.1779 mL5.8893 mL
50 mM0.0471 mL0.2356 mL0.4711 mL2.3557 mL
100 mM0.0236 mL0.1178 mL0.2356 mL1.1779 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy SKLB-197 | purchase SKLB-197 | SKLB-197 cost | order SKLB-197 | SKLB-197 chemical structure | SKLB-197 in vitro | SKLB-197 formula | SKLB-197 molecular weight